Here at Resource Unlimited, we form an evolving relationship with our clients. We treat each and every client as if it were our company. Our staff are businessmen and entrepreneurs themselves, so we understand the needs, discretion, pitfalls and opportunities of running a public company. We welcome any company to contact us for a free consultation to go over your business needs and see if we have solutions to enhance your business at the present time or near future.
OTC: "AABB"
Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets. The Company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertical integration approach to sales transactions is the unique strength of AABB that differentiates the Company and creates distinctive value for shareholders. The Company has recently released its freshly minted mine-to-token gold-backed cryptocurrency AABB Gold token (AABBG) and strives to become a world-wide standard of exchange that is secured and trusted with gold backing, an outstanding quality relative to other cryptocurrencies. WEBSITE: www.asiabroadbandinc.com
PREVIOUS CLIENTS
OTC: "BIXT"
Bioxytran Inc. is a developmental stage biotechnology company. The company is working towards a first-in-class oxygen treatment platform for victims of brain stroke trauma. The first product to proceed to testing is BXT-25, which will be evaluated as a resuscitative agent to treat strokes, especially during the all-critical first hour following a stroke. The product will also be evaluated for its efficacy in treating other brain trauma issues. BXT-25 is based on a new molecule that seems to reverse hypoxia, or oxygen deficiency. During a hypothetical treatment following hypoxic brain injuries such as ischemic strokes, this molecule could be injected intravenously and then bind with oxygen molecules in the lungs in order to carry the oxygen and deliver it to the area blocked by a blood clot, for example. WEBSITE: www.bioxtraninc.com (VIEW: SLIDE DECK PRESENTATION)
OTC: "NSVGF" - CSE: "NVG.CN" - Frankfurt: "3NVN"
Nass Valley Gateway LTD (NVG) is a publicly traded company on the CSE in the Life Sciences category. In late 2018, Nass Valley Gateway agreed to merge with Advanced Bioceuticals Limited, a New Jersey LLC focused on the cultivation, extraction, and sales of organic, non-GMO hemp-based, zero THC, CBD products. Nass Valley CBD products sales will commence in early Q1 2020 under the “Nass Valley Gardens” brand via retail, wholesale, direct response, and digital sales channels. Nass Valley Gateway's products will target the pain remediation, dermatology, anti-aging, and beauty markets. Website: http://www.NassValleyGateway.com
TSX: WNDR -- OTC: WDRFF
Wonderfilm is a leading publicly traded (TSX Venture Exchange) entertainment company with production offices in Los Angeles, corporate offices in Vancouver BC and its Asian distribution office in Seoul, South Korea. Founded by 4 producers, Kirk Shaw, Daniel Grodnik, Jeff Bowler and Bret Saxon, the Company's core business is producing market-driven independent feature films and quality television series for multi-platform global exploitation. Current productions include the feature films, Moose (starring John Travolta) and Primal (starring Nicolas Cage.) Wonderfilm is a producer and distributor only for the projects disclosed. The legal ownership of movie productions are held in a special purpose legal entity held at arm's length to the Company to facilitate for the qualification of various levels of domestic and foreign government tax credit incentives that are customary in the film and production business. WEBSITE: www.wonderfilm.com
OTCQB: "TNTY" now "MITI"
The company's mission is to leverage new technologies and services to improve healthcare and outcomes for individuals, their families, and their pets. They believe they can reduce the cost of healthcare, while improving the quality of life using Telehealth and Telemedicine Solutions.
They are building healthcare applications that focus on: patient engagement, care coordination, remote monitoring, data analytics, and may include Blockchain RX(TM) to provide applications for market participants in healthcare through the encryption of sensitive data.
Their approach is to develop these business opportunities as individual "threads" in response to client needs, ultimately creating and end-to-end set of solutions from the end user up to the healthcare provider, or veterinary professional. Further they expect to assist suppliers to the healthcare industry by allowing them to access unique technologies that bind them with their clients in a "top-down" distribution model.
They recognize it will take the investment of major market participants like Apple, Amazon, IBM, hospitals, healthcare networks, pharmacy and other providers for them to achieve critical mass. In consideration of this reality, they expect to work with these market makers in collaboration, and in support of the ultimate user, the individual, and their pets. The day of "direct-to-consumer" healthcare, including "the humanization of our pets" is upon us, and they hope to be key parties to their evolution, and success. WEBSITE: https://truenaturepharma.com/
OTC: "ETBI"
EastGate Biotech (ETBI) produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. We utilize state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. Our research and development scientists have more than 60 years of combined experience and are dedicated to providing the best nutraceutical products for your natural comfort, health, and well-being. WEBSITE: www.EastgateBiotech.com
NASDAQ: TPIV
TapImmune, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL. INVESTOR PRESENTATION: (CLICK HERE) WEBSITE: https://tapimmune.com/
OTC: "LHGI"
Lighthouse Global Holdings inc.is a diversified holdings company that acquires emerging companies in key industries where rapid revenue growth and market share penetration are poised for significant gains Our main focus is to acquire, invest and partner with companies that have competent management teams with provable experience in their industry and have developed products or services that have a unique edge in their marketplace. Our evaluation matrix and consultant screening process help us filter hundreds of opportunities to effectively pick companies that can grow and evolve into high performing growth entities. WEBSITE: www.LHGIncorp.com
OTC:QB "INTV"
Integrated Ventures, Inc (INTV) is a diversified holdings company that acquires, invests, launches and operates businesses, primarily in the Cryptocurrency sector with focus on digital currency mining and hosting, manufacturing and distribution of the mining equipment and blockchain development with solid operating histories, minimum debt, high growth potential and tangible assets. The company is focused on implementing unique business strategies, creating liquidity through asset based infrastructure, supporting and improving operations, infusing an additional growth capital, maintaining and expanding a market presence in their niche sectors, while constantly enhancing this process by a multitude of initiatives. WEBSITE: www.IntegratedVenturesInc.com
OTC: "DATI"
Digital Arts Media Network is a Public Accelerator-Incubator ("PAI"), trading under the ticker symbol DATI. The Company funds disruptive and sustainable innovations, solving global problems through digital platforms and other electronic applications. Following the global success of private accelerators and incubators, adding to PAI's niche, start-up ventures and developing companies enter into Digital Arts Media Network's accelerator-incubator program, either through an application process, joint venture, acquisition or strategic partnership. The Company aligns itself with other leading private accelerators and incubators, to form unique partnerships. These partnerships enhance the vetting process, to ensure that the best teams, whom are developing the most cutting edge innovations, are properly funded and acquired. Further, Digital Arts Media Network, partners with successful entrepreneurs, venture capitalists, and development teams, to provide startups with general and functional mentorship. Digital Arts Media Network's value is derived from its ability to significantly decrease investment risk, acquire quantifiable assets and generate revenues from multiple channels. The Company also offers all investors the ability to (i) diversify, (ii) maximize success, (iii) see money at work, and (iv) exit, while effectively supporting startup ventures and early stage developing companies. WEBSITE: www.DigitalArtsMediaNetwork.com
